At Hemophilia Outreach Center, we’re committed to more than just medicine — we’re committed to people. Gene therapy is a groundbreaking treatment, but what makes it truly meaningful are the people behind it — the patients who face each day with courage, the care teams who prepare with precision, and the leaders who ensure every individual feels seen, heard, and supported.
In this video series, we’re bringing together the voices of patients and staff — including Mason, who has lived with hemophilia B his entire life — reflects on what led him to pursue gene therapy and how it’s opened the door to a future with fewer infusions, less fear, and more freedom.
For Mason, living with hemophilia B was something he understood well — not just through his own experience, but through watching his uncle and cousin manage their condition. For years, they talked about the idea of a long-term solution. When gene therapy for hemophilia became an option, Mason felt honored — and ready — to take that step forward.
“HOC was there with me from step one. They explained everything, stayed in touch, and made sure I was comfortable through the whole process.”
— Mason Buxton, Gene Therapy Patient
The process leading up to therapy wasn’t rushed. HOC guided him through every stage — from understanding the risks and benefits to managing the follow-up care. Weekly labs, check-ins, reassurance — the team was there, making sure he felt supported the entire way.
“My factor levels started increasing significantly. I actually started making my own factor, which was a first. I’ve never done that before.”
— Mason Buxton, Gene Therapy Patient
That moment marked a major shift. After years of relying on infusions, Mason’s body was producing its own clotting factor — something he never thought possible. One experience brought it all into focus: he slammed his finger in his car trunk, bracing for the bleed and swelling that would usually follow. But it never came. Just a bruise. No treatment needed.
Today, Mason’s story stands as a reminder of what’s possible — not just medically, but personally. Fewer infusions. Less fear. A chance to think about the future in a whole new way.
Looking Ahead Together
Gene therapy for hemophilia represents a new chapter in bleeding disorder care — and HOC is proud to be part of that progress. But even more than that, we’re proud to support our patients with the same level of commitment we always have: personalized, compassionate, full-spectrum care.
Our approach doesn’t change with new treatments — it evolves. We remain focused on education, partnership, and walking alongside each individual on their unique path.
